APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cefazolin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cefazolin Injection Industry Growth and Trends Forecast to 2032

Report ID 17397584012 January 2026102 pages

Choose your research edition.

Industry ResearchCefazolin Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefazolin Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cefazolin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefazolin Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefazolin Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cefazolin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cefazolin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cefazolin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cefazolin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cefazolin Injection include Cefazolin Injection, Hikma, Sagent, Samson Medical Technologies, WG Critical Care, Baxter, B Braun, Chengdu Brilliant Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cefazolin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cefazolin Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cefazolin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cefazolin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cefazolin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cefazolin Injection Market by Company

Cefazolin Injection

Hikma

Sagent

Samson Medical Technologies

WG Critical Care

Baxter

B Braun

Chengdu Brilliant Pharmaceutical

Pfizer

Jincheng Pharma

Sandoz

CSPC Pharmaceutical Group

Cefazolin Injection Segment by Type

1g/50ml

2g/100ml

Cefazolin Injection Segment by Application

Clinics

Hospital

Recovery Center

Cefazolin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefazolin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefazolin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefazolin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefazolin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cefazolin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1g/50ml Table 2. Major Company of 2g/100ml Table 3. Global Cefazolin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 5. Global Cefazolin Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cefazolin Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Cefazolin Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cefazolin Injection Sales by Type (2027-2032) & (W Units) Table 10. Global Cefazolin Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cefazolin Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cefazolin Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Cefazolin Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 15. North America Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 17. Europe Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 21. Latin America Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cefazolin Injection Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Cefazolin Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Cefazolin Injection Industry Trends Table 25. Cefazolin Injection Industry Drivers Table 26. Cefazolin Injection Industry Opportunities and Challenges Table 27. Cefazolin Injection Industry Restraints Table 28. Global Cefazolin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cefazolin Injection Revenue Market Share by Company (2021-2026) Table 30. Global Cefazolin Injection Sales by Company (2021-2026) & (W Units) Table 31. Global Cefazolin Injection Sales Share by Company (2021-2026) Table 32. Global Cefazolin Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cefazolin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cefazolin Injection Major Company Production Sites and Headquarters Table 35. Global Cefazolin Injection Company, Product Type & Application Table 36. Global Cefazolin Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cefazolin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cefazolin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cefazolin Injection Sales by Region (2021-2026) & (W Units) Table 41. Global Cefazolin Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cefazolin Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cefazolin Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Cefazolin Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cefazolin Injection Sales by Region (2027-2032) & (W Units) Table 46. Global Cefazolin Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cefazolin Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cefazolin Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Cefazolin Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cefazolin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 52. Global Cefazolin Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cefazolin Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Cefazolin Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cefazolin Injection Sales by Application (2027-2032) & (W Units) Table 57. Global Cefazolin Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cefazolin Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cefazolin Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Cefazolin Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 62. North America Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 64. Europe Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 68. Latin America Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cefazolin Injection Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Cefazolin Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Cefazolin Injection Company Information Table 72. Cefazolin Injection Business Overview Table 73. Cefazolin Injection Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Cefazolin Injection Cefazolin Injection Product Portfolio Table 75. Cefazolin Injection Recent Development Table 76. Hikma Company Information Table 77. Hikma Business Overview Table 78. Hikma Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hikma Cefazolin Injection Product Portfolio Table 80. Hikma Recent Development Table 81. Sagent Company Information Table 82. Sagent Business Overview Table 83. Sagent Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sagent Cefazolin Injection Product Portfolio Table 85. Sagent Recent Development Table 86. Samson Medical Technologies Company Information Table 87. Samson Medical Technologies Business Overview Table 88. Samson Medical Technologies Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Samson Medical Technologies Cefazolin Injection Product Portfolio Table 90. Samson Medical Technologies Recent Development Table 91. WG Critical Care Company Information Table 92. WG Critical Care Business Overview Table 93. WG Critical Care Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. WG Critical Care Cefazolin Injection Product Portfolio Table 95. WG Critical Care Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Baxter Cefazolin Injection Product Portfolio Table 100. Baxter Recent Development Table 101. B Braun Company Information Table 102. B Braun Business Overview Table 103. B Braun Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. B Braun Cefazolin Injection Product Portfolio Table 105. B Braun Recent Development Table 106. Chengdu Brilliant Pharmaceutical Company Information Table 107. Chengdu Brilliant Pharmaceutical Business Overview Table 108. Chengdu Brilliant Pharmaceutical Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Chengdu Brilliant Pharmaceutical Cefazolin Injection Product Portfolio Table 110. Chengdu Brilliant Pharmaceutical Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer Cefazolin Injection Product Portfolio Table 115. Pfizer Recent Development Table 116. Jincheng Pharma Company Information Table 117. Jincheng Pharma Business Overview Table 118. Jincheng Pharma Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jincheng Pharma Cefazolin Injection Product Portfolio Table 120. Jincheng Pharma Recent Development Table 121. Sandoz Company Information Table 122. Sandoz Business Overview Table 123. Sandoz Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sandoz Cefazolin Injection Product Portfolio Table 125. Sandoz Recent Development Table 126. CSPC Pharmaceutical Group Company Information Table 127. CSPC Pharmaceutical Group Business Overview Table 128. CSPC Pharmaceutical Group Cefazolin Injection Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. CSPC Pharmaceutical Group Cefazolin Injection Product Portfolio Table 130. CSPC Pharmaceutical Group Recent Development Table 131. North America Cefazolin Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. North America Cefazolin Injection Sales by Country (2021-2026) & (W Units) Table 133. North America Cefazolin Injection Sales Market Share by Country (2021-2026) Table 134. North America Cefazolin Injection Sales Forecast by Country (2027-2032) & (W Units) Table 135. North America Cefazolin Injection Sales Market Share Forecast by Country (2027-2032) Table 136. North America Cefazolin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Cefazolin Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Cefazolin Injection Market Share by Country (2021-2026) Table 139. North America Cefazolin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Cefazolin Injection Market Share Forecast by Country (2027-2032) Table 141. Europe Cefazolin Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Europe Cefazolin Injection Sales by Country (2021-2026) & (W Units) Table 143. Europe Cefazolin Injection Sales Market Share by Country (2021-2026) Table 144. Europe Cefazolin Injection Sales Forecast by Country (2027-2032) & (W Units) Table 145. Europe Cefazolin Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Cefazolin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Cefazolin Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Cefazolin Injection Market Share by Country (2021-2026) Table 149. Europe Cefazolin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Cefazolin Injection Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Cefazolin Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Cefazolin Injection Sales by Country (2021-2026) & (W Units) Table 153. Asia-Pacific Cefazolin Injection Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Cefazolin Injection Sales Forecast by Country (2027-2032) & (W Units) Table 155. Asia-Pacific Cefazolin Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Cefazolin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Cefazolin Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Cefazolin Injection Market Share by Country (2021-2026) Table 159. Asia-Pacific Cefazolin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Cefazolin Injection Market Share Forecast by Country (2027-2032) Table 161. Latin America Cefazolin Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Latin America Cefazolin Injection Sales by Country (2021-2026) & (W Units) Table 163. Latin America Cefazolin Injection Sales Market Share by Country (2021-2026) Table 164. Latin America Cefazolin Injection Sales Forecast by Country (2027-2032) & (W Units) Table 165. Latin America Cefazolin Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Cefazolin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Cefazolin Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Cefazolin Injection Market Share by Country (2021-2026) Table 169. Latin America Cefazolin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Cefazolin Injection Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Cefazolin Injection Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Cefazolin Injection Sales by Country (2021-2026) & (W Units) Table 173. Middle East and Africa Cefazolin Injection Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Cefazolin Injection Sales Forecast by Country (2027-2032) & (W Units) Table 175. Middle East and Africa Cefazolin Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Cefazolin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Cefazolin Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Cefazolin Injection Market Share by Country (2021-2026) Table 179. Middle East and Africa Cefazolin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Cefazolin Injection Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Cefazolin Injection Distributors List Table 184. Cefazolin Injection Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Cefazolin Injection Image Figure 2. Global Cefazolin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefazolin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefazolin Injection Sales (2021-2032) & (W Units) Figure 5. 1g/50ml Image Figure 6. Global 1g/50ml Sales YoY Growth (2021-2032) & (W Units) Figure 7. 2g/100ml Image Figure 8. Global 2g/100ml Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Cefazolin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cefazolin Injection Market Share by Type 2025 VS 2032 Figure 11. North America Cefazolin Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Cefazolin Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Cefazolin Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cefazolin Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cefazolin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cefazolin Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cefazolin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cefazolin Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cefazolin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cefazolin Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cefazolin Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinics Image Figure 24. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 27. Recovery Center Image Figure 28. Global Recovery Center Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Cefazolin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cefazolin Injection Market Share by Application 2025 VS 2032 Figure 31. North America Cefazolin Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Cefazolin Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Cefazolin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cefazolin Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cefazolin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cefazolin Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cefazolin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cefazolin Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cefazolin Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cefazolin Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Cefazolin Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Cefazolin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cefazolin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cefazolin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cefazolin Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Cefazolin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cefazolin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cefazolin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cefazolin Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Cefazolin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cefazolin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cefazolin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cefazolin Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Cefazolin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cefazolin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cefazolin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cefazolin Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Cefazolin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cefazolin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cefazolin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cefazolin Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cefazolin Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 1g/50ml
  • 2g/100ml
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • Cefazolin Injection
  • Hikma
  • Sagent
  • Samson Medical Technologies
  • WG Critical Care
  • Baxter
  • B Braun
  • Chengdu Brilliant Pharmaceutical
  • Pfizer
  • Jincheng Pharma
  • Sandoz
  • CSPC Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cefazolin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cefazolin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cefazolin Injection Market by Type
  6. 1.3.1 1g/50ml
  7. 1.3.2 2g/100ml
  8. 1.4 Global Cefazolin Injection Market Size by Type
  9. 1.4.1 Global Cefazolin Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cefazolin Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cefazolin Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cefazolin Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cefazolin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cefazolin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cefazolin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cefazolin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cefazolin Injection Industry Trends
  2. 2.2 Cefazolin Injection Industry Drivers
  3. 2.3 Cefazolin Injection Industry Opportunities and Challenges
  4. 2.4 Cefazolin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cefazolin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cefazolin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cefazolin Injection Price (2021-2026)
  4. 3.4 Global Cefazolin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefazolin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cefazolin Injection Company, Product Type & Application
  7. 3.7 Global Cefazolin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefazolin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefazolin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefazolin Injection Tier 1, Tier 2, and Tier 3
4 Cefazolin Injection Regional Status and Outlook
  1. 4.1 Global Cefazolin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cefazolin Injection Historic Market Size by Region
  3. 4.2.1 Global Cefazolin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cefazolin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cefazolin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cefazolin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cefazolin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cefazolin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cefazolin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cefazolin Injection by Application
  1. 5.1 Cefazolin Injection Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Cefazolin Injection Market Size by Application
  6. 5.2.1 Global Cefazolin Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cefazolin Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cefazolin Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cefazolin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cefazolin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cefazolin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cefazolin Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cefazolin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cefazolin Injection
  2. 6.1.1 Cefazolin Injection Company Information
  3. 6.1.2 Cefazolin Injection Business Overview
  4. 6.1.3 Cefazolin Injection Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cefazolin Injection Cefazolin Injection Product Portfolio
  6. 6.1.5 Cefazolin Injection Recent Developments
  7. 6.2 Hikma
  8. 6.2.1 Hikma Company Information
  9. 6.2.2 Hikma Business Overview
  10. 6.2.3 Hikma Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hikma Cefazolin Injection Product Portfolio
  12. 6.2.5 Hikma Recent Developments
  13. 6.3 Sagent
  14. 6.3.1 Sagent Company Information
  15. 6.3.2 Sagent Business Overview
  16. 6.3.3 Sagent Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sagent Cefazolin Injection Product Portfolio
  18. 6.3.5 Sagent Recent Developments
  19. 6.4 Samson Medical Technologies
  20. 6.4.1 Samson Medical Technologies Company Information
  21. 6.4.2 Samson Medical Technologies Business Overview
  22. 6.4.3 Samson Medical Technologies Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Samson Medical Technologies Cefazolin Injection Product Portfolio
  24. 6.4.5 Samson Medical Technologies Recent Developments
  25. 6.5 WG Critical Care
  26. 6.5.1 WG Critical Care Company Information
  27. 6.5.2 WG Critical Care Business Overview
  28. 6.5.3 WG Critical Care Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 WG Critical Care Cefazolin Injection Product Portfolio
  30. 6.5.5 WG Critical Care Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Cefazolin Injection Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 B Braun
  38. 6.7.1 B Braun Company Information
  39. 6.7.2 B Braun Business Overview
  40. 6.7.3 B Braun Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 B Braun Cefazolin Injection Product Portfolio
  42. 6.7.5 B Braun Recent Developments
  43. 6.8 Chengdu Brilliant Pharmaceutical
  44. 6.8.1 Chengdu Brilliant Pharmaceutical Company Information
  45. 6.8.2 Chengdu Brilliant Pharmaceutical Business Overview
  46. 6.8.3 Chengdu Brilliant Pharmaceutical Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chengdu Brilliant Pharmaceutical Cefazolin Injection Product Portfolio
  48. 6.8.5 Chengdu Brilliant Pharmaceutical Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Cefazolin Injection Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Jincheng Pharma
  56. 6.10.1 Jincheng Pharma Company Information
  57. 6.10.2 Jincheng Pharma Business Overview
  58. 6.10.3 Jincheng Pharma Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jincheng Pharma Cefazolin Injection Product Portfolio
  60. 6.10.5 Jincheng Pharma Recent Developments
  61. 6.11 Sandoz
  62. 6.11.1 Sandoz Company Information
  63. 6.11.2 Sandoz Business Overview
  64. 6.11.3 Sandoz Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sandoz Cefazolin Injection Product Portfolio
  66. 6.11.5 Sandoz Recent Developments
  67. 6.12 CSPC Pharmaceutical Group
  68. 6.12.1 CSPC Pharmaceutical Group Company Information
  69. 6.12.2 CSPC Pharmaceutical Group Business Overview
  70. 6.12.3 CSPC Pharmaceutical Group Cefazolin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSPC Pharmaceutical Group Cefazolin Injection Product Portfolio
  72. 6.12.5 CSPC Pharmaceutical Group Recent Developments
7 North America by Country
  1. 7.1 North America Cefazolin Injection Sales by Country
  2. 7.1.1 North America Cefazolin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cefazolin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cefazolin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cefazolin Injection Market Size by Country
  6. 7.2.1 North America Cefazolin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cefazolin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cefazolin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cefazolin Injection Sales by Country
  2. 8.1.1 Europe Cefazolin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cefazolin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cefazolin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cefazolin Injection Market Size by Country
  6. 8.2.1 Europe Cefazolin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cefazolin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cefazolin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cefazolin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cefazolin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cefazolin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cefazolin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cefazolin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cefazolin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cefazolin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cefazolin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cefazolin Injection Sales by Country
  2. 10.1.1 South America Cefazolin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cefazolin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cefazolin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cefazolin Injection Market Size by Country
  6. 10.2.1 South America Cefazolin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cefazolin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cefazolin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cefazolin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cefazolin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cefazolin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cefazolin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cefazolin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cefazolin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cefazolin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cefazolin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cefazolin Injection Value Chain Analysis
  2. 12.1.1 Cefazolin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cefazolin Injection Production Mode & Process
  7. 12.2 Cefazolin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cefazolin Injection Distributors
  10. 12.2.3 Cefazolin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst